1. Symptomatic treatment of cognitive/intellectual or memory deficits (excluding Alzheimer disease and other dementias)
2. Adjunctive treatment of cortical myoclonus

Antimyoclonic, Miscellaneous; Nootropic

Absorption：Bioavailability nearly 100%, Time to peak(serum) 30 minutes
Distribution:Vd 0.6L/kg
Excretion: urine(100%), half life 4-5 hours

Hypersensitivity to Piracetam, pyrrolidone, or any component of the formulation.
End stage renal disease, Phenylketonurics, Intracranial hemorrhage.

Vertigo, Abdomen pain, Diarrhea, Vomitting, Hypersensitivity, Headache, Sleepy, Insomnia, Anxiety, Skin rash

Cognitive disorders: 1.2-4.8 g/day in 2-4 divided doses
Cortical myoclonus, adjunctive: Initial 7.2 g/day in 2-3 divided doses; may increase total daily dose by 4.8 g every 3 to 4 days if needed; maximum daily dose: 24 g

Children 8-13 years: 3.3 g/day in 2 divided doses

CrCl >80: Original dose, in 2-4 divided doses
CrCl 50-79: 2/3 of original dose, in 2-3 divided doses
CrCl 30-49: 1/3 of original dose, BID
CrCl <30: 1/6 of original dose, QD
CrCl <20(ESRD): Contraindication